Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 1
2005 2
2006 4
2007 3
2008 4
2009 1
2010 3
2011 7
2012 3
2013 3
2014 6
2015 9
2016 12
2017 16
2018 11
2019 11
2020 11
2021 18
2022 15
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Results by year

Filters applied: . Clear all
Page 1
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.
Xiao L, Parolia A, Qiao Y, Bawa P, Eyunni S, Mannan R, Carson SE, Chang Y, Wang X, Zhang Y, Vo JN, Kregel S, Simko SA, Delekta AD, Jaber M, Zheng H, Apel IJ, McMurry L, Su F, Wang R, Zelenka-Wang S, Sasmal S, Khare L, Mukherjee S, Abbineni C, Aithal K, Bhakta MS, Ghurye J, Cao X, Navone NM, Nesvizhskii AI, Mehra R, Vaishampayan U, Blanchette M, Wang Y, Samajdar S, Ramachandra M, Chinnaiyan AM. Xiao L, et al. Among authors: wang x. Nature. 2022 Jan;601(7893):434-439. doi: 10.1038/s41586-021-04246-z. Epub 2021 Dec 22. Nature. 2022. PMID: 34937944 Free PMC article.
Corrigenda.
Wang X, Wang D, Xia P, Cheng K, Wang Q, Wang X, Lin Q, Song J, Chen A, Li X. Wang X, et al. Bone Joint Res. 2022 Apr;11(4):251. doi: 10.1302/2046-3758.114.BJR-2022-00002. Bone Joint Res. 2022. PMID: 35475378 Free PMC article. No abstract available.
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.
Parolia A, Cieslik M, Chu SC, Xiao L, Ouchi T, Zhang Y, Wang X, Vats P, Cao X, Pitchiaya S, Su F, Wang R, Feng FY, Wu YM, Lonigro RJ, Robinson DR, Chinnaiyan AM. Parolia A, et al. Among authors: wang x. Nature. 2019 Jul;571(7765):413-418. doi: 10.1038/s41586-019-1347-4. Epub 2019 Jun 26. Nature. 2019. PMID: 31243372 Free PMC article.
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer.
Qiao Y, Choi JE, Tien JC, Simko SA, Rajendiran T, Vo JN, Delekta AD, Wang L, Xiao L, Hodge NB, Desai P, Mendoza S, Juckette K, Xu A, Soni T, Su F, Wang R, Cao X, Yu J, Kryczek I, Wang XM, Wang X, Siddiqui J, Wang Z, Bernard A, Fernandez-Salas E, Navone NM, Ellison SJ, Ding K, Eskelinen EL, Heath EI, Klionsky DJ, Zou W, Chinnaiyan AM. Qiao Y, et al. Among authors: wang x. Nat Cancer. 2021 Sep;2:978-993. doi: 10.1038/s43018-021-00237-1. Epub 2021 Aug 2. Nat Cancer. 2021. PMID: 34738088 Free PMC article.
An Overview on Small Molecule Inhibitors of BRD4.
Huang W, Zheng X, Yang Y, Wang X, Shen Z. Huang W, et al. Among authors: wang x. Mini Rev Med Chem. 2016;16(17):1403-1414. doi: 10.2174/1389557516666160611014130. Mini Rev Med Chem. 2016. PMID: 27290915 Review.
Molecular markers of prostate cancer.
Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Bradford TJ, et al. Among authors: wang x. Urol Oncol. 2006 Nov-Dec;24(6):538-51. doi: 10.1016/j.urolonc.2006.07.004. Urol Oncol. 2006. PMID: 17138135 Review.
144 results